Evidence map›Paper›PMID 42681395›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Targeted Degradation of Mouse Embryo Proteins Using Trim-Away.

Thomas Nolte, Steffen Israel, Michele Boiani

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Thomas NolteMax Planck Institute for Molecular Biomedicine, Muenster, Germany.
Steffen IsraelMax Planck Institute for Molecular Biomedicine, Muenster, Germany.
Michele BoianiMax Planck Institute for Molecular Biomedicine, Muenster, Germany. mboiani@mpi-muenster.mpg.de.ORCID http://orcid.org/0000-0003-2765-2781

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trim-Away is an antibody-based method for the degradation of endogenous cellular proteins without prior genetic manipulation. From the effect that protein degradation has on the phenotype, one can infer the function of the protein-coding gene. Among the strengths of Trim-Away, the authors highlight the possibility to target embryonic proteins that have not yet been produced or are not yet functionally required at the time of antibody delivery. Conversely, a limitation of Trim-Away is the possibility that while the target protein is being degraded, de novo translation may replenish it, whereby the two processes offset each other, and the phenotype is inconspicuous. Appropriate controls, as described, are therefore essential for the correct interpretation of Trim-Away results. With these considerations in mind, the authors provide guidance on how to set up a Trim-Away experiment in fertilized mouse oocytes, using microinjection as the delivery method and the epithelial CADHERIN protein as an example.

Indexed as

AntibodiesEmbryo, MammalianProteolysisRibonucleoproteinsAnimalsCadherinsFemaleMiceMicroinjectionsOocytesRNA, MessengerSS-A AntigenTRIM21 ProteinAntibodiesCadherinsRibonucleoproteinsRNA, MessengerSS-A AntigenTRIM21 ProteinAntibodyE-CADHERINMouseOocyteProtein of interest (POI)Trim21 mRNATRIM 21 protein

Identifiers

PMID42681395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.